These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6201285)

  • 1. Regulation of natural killer cell activity by anti-I-region monoclonal antibodies.
    Sharma SD; Budzich T; Proffitt MR; Shepherd D; Remington JS
    Cell Immunol; 1984 Apr; 85(1):125-34. PubMed ID: 6201285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to immune response gene products inhibit the IgM and IgG antibody response but not the development of resistance to Toxoplasma gondii.
    Sharma SD; Shepard D; Remington JS
    Cell Immunol; 1986 Apr; 98(2):323-32. PubMed ID: 3489548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii.
    Hauser WE; Sharma SD; Remington JS
    J Immunol; 1983 Jul; 131(1):458-63. PubMed ID: 6190921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
    Wright SC; Bonavida B
    J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain difference in mouse natural killer activity augmented by mouse interferon and poly I.C.
    Kiuchi Y
    Jikken Dobutsu; 1986 Jul; 35(3):239-44. PubMed ID: 2429851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T; Alm G; Stålhandshe T
    J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of T cell activation in vivo with mixtures of monoclonal antibodies specific for I-A and I-A/E molecules.
    Sprent J; Lerner EA; Bruce J; Symington FW
    J Exp Med; 1981 Jul; 154(1):188-92. PubMed ID: 6166722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of I-A-restricted B-B cell interaction in the polyclonal B cell differentiation induced by lipopolysaccharide.
    Takahama Y; Ono S; Ishihara K; Muramatsu M; Hamaoka T
    Adv Exp Med Biol; 1990; 256():427-43. PubMed ID: 2327298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells.
    Aberer W; Kruisbeek AM; Shimada S; Katz SI
    J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-induced augmentation of murine natural killer cell activity.
    Brunda MJ; Herberman RB; Holden HT
    Int J Cancer; 1981 Feb; 27(2):205-11. PubMed ID: 7287215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using a monoclonal rat anti-murine macrophage antibody (M1/70).
    Holmberg LA; Springer TA; Ault KA
    J Immunol; 1981 Nov; 127(5):1792-9. PubMed ID: 6795262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine NK cell heterogeneity: subpopulations of C57BL/6 splenic NK cells detected by NK-1.1 and NK-2.1 antisera.
    Emmons SL; Pollack SB
    Nat Immun Cell Growth Regul; 1985; 4(4):169-77. PubMed ID: 4069121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented followed by suppressed levels of natural cell-mediated cytotoxicity in mice infected with Toxoplasma gondii.
    Kamiyama T; Hagiwara T
    Infect Immun; 1982 May; 36(2):628-36. PubMed ID: 6177634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of a role for natural killer cells in the control of acute infection by Toxoplasma gondii oocysts.
    Hughes HP; Kasper LH; Little J; Dubey JP
    Clin Exp Immunol; 1988 Jun; 72(3):394-9. PubMed ID: 3139341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice.
    Suzuki Y; Joh K; Orellana MA; Conley FK; Remington JS
    Immunology; 1991 Dec; 74(4):732-9. PubMed ID: 1783431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.